|
Name: CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl]-phenol)
Type: Synthetic cannabinoid
AKA: CP-47, 497 C8 Homologue
![CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl]-phenol) image](https://grammasearch.com/dev/v2/aiimages/cp-47%2C497_c8_homologue_%285-%281%2C1-dimethyloctyl%29-2-%5B%281r%2C3s%293-hydroxycyclohexyl%5D-phenol%29.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
![CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl]-phenol) image](/dev/v2/pages/pubchem_images/3080428.png)
|
|
IV. History
CP-47,497 C8 homologue is a synthetic cannabinoid developed in the 1990s. It is part of research into cannabinoid receptors and has been studied for its psychoactive effects. Its use has led to regulatory actions due to its potential for abuse and health risks.
|
|
V. Legal Information
CP-47,497 C8 homologue, a synthetic cannabinoid, is often regulated under analog laws due to its psychoactive effects. In the US, it might be controlled under the Federal Analog Act if deemed similar to other controlled substances.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
CP-47,497 C8 Homologue is a synthetic cannabinoid with strong psychoactive effects. As an upper, it induces euphoria and altered perception. Short-term effects include increased heart rate and potential anxiety, while long-term use may lead to psychological issues. Overdose risks involve severe agitation and cardiovascular problems. Safe use involves cautious dosing, and recent research highlights its potency and risks.  |
|
VII. Psychological Effects
CP-47,497 C8 homologue, a synthetic cannabinoid, affects cannabinoid receptors, leading to altered mood and perception. Immediate effects include euphoria and relaxation, with long-term use potentially causing cognitive impairments and psychological issues. Research focuses on its safety and psychological impact.
 |
|
VIII. Culture
CP-47,497 C8 Homologue is a synthetic cannabinoid with no historical or cultural lore, emerging in the 21st century. Its cultural significance is related to its use as a legal high and the associated health risks. Proponents highlight its effects and legal status in certain regions, while opponents warn of unpredictable effects and health risks. Its use is primarily recreational, reflecting broader issues in synthetic drug regulation.
 |